ANEBULO PHARMACEUTICALS, INC. Shareholders' Equity
ANEBULO PHARMACEUTICALS, INC. (ANEB) had Shareholders' Equity of $7.94 million as of 2025-12-31, per its 10-Q filed 2026-02-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-02-12
- 2025-12-31: Stockholders' Equity Attributable to Parent $7.94M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $9.74M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $11.66M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $13.46M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | $7.94M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $9.74M 10-Q · filed 2026-02-12 |
| 2025-06-30 | $11.66M 10-Q · filed 2026-02-12 |
| 2025-03-31 | $13.46M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $14.96M 10-Q · filed 2026-02-12 |
| 2024-09-30 | $1.90M 10-Q · filed 2026-02-12 |
| 2024-06-30 | $3.81M 10-Q · filed 2026-02-12 |
| 2024-03-31 | $4.99M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $6.49M 10-Q · filed 2025-05-13 |
| 2023-09-30 | $8.33M 10-Q · filed 2025-05-13 |
| 2023-06-30 | $10.60M 10-K · filed 2025-09-29 |
| 2023-03-31 | $12.94M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $15.52M 10-Q · filed 2024-05-15 |
| 2022-09-30 | $19.12M 10-Q · filed 2024-05-15 |
| 2022-06-30 | $15.07M 10-K · filed 2024-09-25 |
| 2022-03-31 | $17.16M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $18.91M 10-Q · filed 2023-05-11 |
| 2021-09-30 | $19.89M 10-Q · filed 2023-05-11 |
| 2021-06-30 | $21.41M 10-K · filed 2023-09-22 |
| 2021-03-31 | -$9.44M 10-Q · filed 2022-05-11 |
| 2020-12-31 | -$719.02K 10-Q · filed 2022-05-11 |
| 2020-09-30 | -$411.11K 10-Q · filed 2022-05-11 |
| 2020-06-30 | -$171.14K 10-K · filed 2022-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |